computer optimizing software plato version 14.2 (Nucletron B V)
90
Structured Review
Nucletron B V
computer optimizing software plato version 14.2
Computer Optimizing Software Plato Version 14.2, supplied by Nucletron B V, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer+optimizing+software+plato+version+14%2E2/computer+optimizing+software+plato+version+14+2/pm20932653-61-7-10
Average 90 stars, based on 1 article reviews
Computer Optimizing Software Plato Version 14.2, supplied by Nucletron B V, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer+optimizing+software+plato+version+14%2E2/computer+optimizing+software+plato+version+14+2/pm20932653-61-7-10
Average 90 stars, based on 1 article reviews
computer optimizing software plato version 14.2 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Software:Article Title: Objective and longitudinal assessment of dermatitis after postoperative accelerated partial breast irradiation using high-dose-rate interstitial brachytherapy in patients with breast cancer treated with breast conserving therapy: reduction of moisture deterioration by APBI. Article Snippet: Reprin diology, K Kawaram (81) 75-2 hotmail.c Purpose: To objectively evaluate the radiation dermatitis caused by accelerated partial breast irradiation (APBI) using high-dose-rate interstitial brachytherapy.. Patients andMethods: The skin color andmoisture changes were examined using a newly installed spectrophotometer and corneometer in 22 patients who had undergone APBI using open cavity implant high-dose-rate interstitial brachytherapy (36 Gy in six fractions) and compared with the corresponding values for 44 patients in an external beam radiotherapy (EBRT) control group (50–60 Gy in 25–30 fractions within 5–6 weeks) after breast conserving surgery.. Results: All values changed significantly as a result of APBI. Article Title: Preliminary result of accelerated partial breast irradiation after breast-conserving surgery. Article Snippet: Purpose To investigate the feasibility of accelerated partial breast irradiation (APBI) for Japanese patients, we started high-dose-rate interstitial brachytherapy (HDRISBT) as monotherapy after breast-conserving surgery (BCS).. Methods We implanted 45 Tis-2 breast cancer patients at National Hospital Organization Osaka National Hospital between June 2002 and June 2006.. Our eligibility criteria were broader than the ones used previously in western countries. Modification:Article Title: Objective and longitudinal assessment of dermatitis after postoperative accelerated partial breast irradiation using high-dose-rate interstitial brachytherapy in patients with breast cancer treated with breast conserving therapy: reduction of moisture deterioration by APBI. Article Snippet: Reprin diology, K Kawaram (81) 75-2 hotmail.c Purpose: To objectively evaluate the radiation dermatitis caused by accelerated partial breast irradiation (APBI) using high-dose-rate interstitial brachytherapy.. Patients andMethods: The skin color andmoisture changes were examined using a newly installed spectrophotometer and corneometer in 22 patients who had undergone APBI using open cavity implant high-dose-rate interstitial brachytherapy (36 Gy in six fractions) and compared with the corresponding values for 44 patients in an external beam radiotherapy (EBRT) control group (50–60 Gy in 25–30 fractions within 5–6 weeks) after breast conserving surgery.. Results: All values changed significantly as a result of APBI. Article Title: Preliminary result of accelerated partial breast irradiation after breast-conserving surgery. Article Snippet: Purpose To investigate the feasibility of accelerated partial breast irradiation (APBI) for Japanese patients, we started high-dose-rate interstitial brachytherapy (HDRISBT) as monotherapy after breast-conserving surgery (BCS).. Methods We implanted 45 Tis-2 breast cancer patients at National Hospital Organization Osaka National Hospital between June 2002 and June 2006.. Our eligibility criteria were broader than the ones used previously in western countries. |